Is Pharma Geared For Big Efficiency Pay-Offs?
Executive Summary
Driving operational efficiencies may not seem exciting in an industry that's racing towards newer cures for cancer and where firms like Google Life Sciences (now Verily) are working towards putting computing inside a contact lens. But a look at some interesting data reveals why drab may sometimes be fab for an industry that's grappling with unprecedented pricing pressures, patent expiries, growing compliance requirements and more.